RS51033B - Postupak i intermedijati za dobijanje olanzapina - Google Patents
Postupak i intermedijati za dobijanje olanzapinaInfo
- Publication number
- RS51033B RS51033B YUP-2005/0543A YUP20050543A RS51033B RS 51033 B RS51033 B RS 51033B YU P20050543 A YUP20050543 A YU P20050543A RS 51033 B RS51033 B RS 51033B
- Authority
- RS
- Serbia
- Prior art keywords
- olanzapine
- intermediates
- preparation
- well
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Postupci za proizvodnju Olanzapine prema formuli I ili njegova so:naznačen time što se pretvara jedinjenje prema formuli II ili njegova sou kojoj(i) R1 i R2 zajedno daju =CH-CH2-CH3, ili(ii) R1 i R2 su zajedno H, ili(iii) R1 je H i R2 je-CH(R3)-CH2-CH3, pri čemu je R3 odlazeća grupa koja može biti eliminisana zajedno sa R1 što omogućuje da R1 i R2 zajedno formiraju=CH-CH2-CH3da se dobije Olanzapin ili njegova so. Prijava sadrži još 9 patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10301923A DE10301923B3 (de) | 2003-01-17 | 2003-01-17 | Verfahren und Zwischenprodukte zur Herstellung von Olanzapin |
PCT/EP2004/000299 WO2004065390A1 (en) | 2003-01-17 | 2004-01-16 | Process and intermediates for the preparation of olanzapine |
Publications (2)
Publication Number | Publication Date |
---|---|
RS20050543A RS20050543A (en) | 2007-06-04 |
RS51033B true RS51033B (sr) | 2010-10-31 |
Family
ID=32747459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0543A RS51033B (sr) | 2003-01-17 | 2004-01-16 | Postupak i intermedijati za dobijanje olanzapina |
Country Status (11)
Country | Link |
---|---|
US (1) | US7498433B2 (sr) |
EP (1) | EP1594879B1 (sr) |
AT (1) | ATE411999T1 (sr) |
DE (2) | DE10301923B3 (sr) |
EA (1) | EA007950B1 (sr) |
ES (1) | ES2316955T3 (sr) |
NO (1) | NO331720B1 (sr) |
PT (1) | PT1594879E (sr) |
RS (1) | RS51033B (sr) |
SI (1) | SI1594879T1 (sr) |
WO (1) | WO2004065390A1 (sr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7323459B2 (en) | 2002-12-24 | 2008-01-29 | Teva Pharmaceutical Industries Ltd. | Crystal forms, methods for their preparation and method for preparation of olanzapine |
CA2551806A1 (en) * | 2003-12-22 | 2005-07-14 | Teva Pharmaceutical Industries, Ltd. | Methods of preparing olanzapine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
2003
- 2003-01-17 DE DE10301923A patent/DE10301923B3/de not_active Expired - Fee Related
-
2004
- 2004-01-16 US US10/541,604 patent/US7498433B2/en not_active Expired - Fee Related
- 2004-01-16 RS YUP-2005/0543A patent/RS51033B/sr unknown
- 2004-01-16 SI SI200430996T patent/SI1594879T1/sl unknown
- 2004-01-16 EP EP04702675A patent/EP1594879B1/en not_active Expired - Lifetime
- 2004-01-16 ES ES04702675T patent/ES2316955T3/es not_active Expired - Lifetime
- 2004-01-16 AT AT04702675T patent/ATE411999T1/de not_active IP Right Cessation
- 2004-01-16 DE DE602004017281T patent/DE602004017281D1/de not_active Expired - Lifetime
- 2004-01-16 PT PT04702675T patent/PT1594879E/pt unknown
- 2004-01-16 WO PCT/EP2004/000299 patent/WO2004065390A1/en active Application Filing
- 2004-01-16 EA EA200501137A patent/EA007950B1/ru not_active IP Right Cessation
-
2005
- 2005-08-15 NO NO20053829A patent/NO331720B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1594879B1 (en) | 2008-10-22 |
PT1594879E (pt) | 2008-11-14 |
US7498433B2 (en) | 2009-03-03 |
EA200501137A1 (ru) | 2006-02-24 |
NO331720B1 (no) | 2012-03-05 |
ATE411999T1 (de) | 2008-11-15 |
US20060040921A1 (en) | 2006-02-23 |
EP1594879A1 (en) | 2005-11-16 |
EA007950B1 (ru) | 2007-02-27 |
DE10301923B3 (de) | 2004-09-16 |
DE602004017281D1 (de) | 2008-12-04 |
NO20053829D0 (no) | 2005-08-15 |
ES2316955T3 (es) | 2009-04-16 |
SI1594879T1 (sl) | 2009-04-30 |
WO2004065390A8 (en) | 2004-12-16 |
WO2004065390A1 (en) | 2004-08-05 |
RS20050543A (en) | 2007-06-04 |
NO20053829L (no) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL244803B (en) | Human anti-beta antibodies and their use | |
IL172357A0 (en) | Method for the production of substituted 3-aryl-butyl amine compounds | |
TW200624426A (en) | BACE inhibitors | |
TW200508201A (en) | Novel process for the preparation of roflumilast | |
TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
SG145744A1 (en) | Process for the preparation of 4-amino-3- quinolinecarbonitriles | |
AU5721301A (en) | Zolpidem hemitartrate | |
IL175634A0 (en) | Methods of preparing olanzapine | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
CY1105980T1 (el) | Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου | |
SG142306A1 (en) | Methods for neuroprotection | |
TW200510323A (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
HUP0600231A2 (en) | Novel process for the preparation of 2h-chromenes | |
MXPA03008946A (es) | Metodos para sintetizar compuestos que contienen fenol. | |
SG144912A1 (en) | Process for the asymmetric hydrogenation of beta-amino ketones | |
NO20053829D0 (no) | Fremgangsmate og intermediater for fremstilling av olanzapin. | |
EP1615897A4 (en) | PYRIMIDINONE COMPOUNDS AS CALCILYTICA | |
EP1436279A4 (en) | CHEMICAL COMPOUNDS | |
HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
WO2004096828A3 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes | |
MXPA03005400A (es) | Metodo para preparacion de 11 (12)-pentadecen-15-olidos. | |
MXPA04004757A (es) | Uso de una ascomicina para el tratamiento de blefaritis. | |
MXPA05009152A (es) | Preparacion de k-252a. | |
TW200504218A (en) | Methods for preventing gluconoylation of proteins | |
HU0300255D0 (en) | Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine |